Question 1

What is the catalog number for Farletuzumab-MMAE?

Accepted Answer

The catalog number for Farletuzumab-MMAE is orb1910484.

Question 2

What sizes are available for Farletuzumab-MMAE?

Accepted Answer

Farletuzumab-MMAE is available in the following size(s): 100 µg, 1 mg, 5 mg.

Question 3

How many pack sizes does Farletuzumab-MMAE come in?

Accepted Answer

Farletuzumab-MMAE is available in 3 different pack sizes.

Question 4

Is Farletuzumab-MMAE in stock?

Accepted Answer

Farletuzumab-MMAE is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Farletuzumab-MMAE used for?

Accepted Answer

Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

Question 6

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 7

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 8

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Farletuzumab-MMAE

Product Specifications

Purity

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

CD34 (ICO-115), CF640R conjugate, 0.1mg/mL

CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL

Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL

CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL

CD53 (161-2), CF647 conjugate, 0.1mg/mL

Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (LL025), CF568 conjugate, 0.1mg/mL